glp 1 and high blood pressure GLP-1 for Weight Loss Diabetes GLP-1 Receptor Agonists and Blood
Description
Back to Journals Drug Design, Development and Therapy Volume 16 The Role of Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RA) in Diabetes-Related Neurodegenerative Diseases Authors Cheng D, Yang S, Zhao X, Wang G Received 5 November 2021 Accepted for publication 18 February 2022 Published 14 March 2022 Volume 2022:16 Pages 665684 DOI Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 2 Editor who approved publication: Dr Tuo Deng Dihe Cheng, Shuo Yang, Xue Zhao, Guixia Wang Department of Endocrinology and Metabolism, The First Hospital of Jilin University, Changchun, 130021, Peoples Republic of China Correspondence: Guixia Wang
Multi-functional GLP-1RA peptides demonstrate superior efficacy, but their administration is still limited now
No significant differences in weight loss and improvement in glycosylated hemoglobin levels were found between liraglutide responders and non-responders
Making these changes has saved my life
Travel patterns, work schedule, eating windows, family routines, ability to follow a daily versus weekly schedule
